- Home
- OCGN vs MVIS Comparison
OCGN vs MVIS Comparison
Compare OCGN & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- MVIS
- Stock Information
- Founded
- OCGN 2013
- MVIS 1993
- Country
- OCGN United States
- MVIS United States
- Employees
- OCGN N/A
- MVIS N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- MVIS Industrial Machinery/Components
- Sector
- OCGN Health Care
- MVIS Technology
- Exchange
- OCGN Nasdaq
- MVIS Nasdaq
- Market Cap
- OCGN 252.4M
- MVIS 234.3M
- IPO Year
- OCGN N/A
- MVIS 1996
- Fundamental
- Price
- OCGN $0.91
- MVIS $1.02
- Analyst Decision
- OCGN Strong Buy
- MVIS Hold
- Analyst Count
- OCGN 3
- MVIS 2
- Target Price
- OCGN $5.67
- MVIS $3.00
- AVG Volume (30 Days)
- OCGN 4.3M
- MVIS 2.2M
- Earning Date
- OCGN 11-08-2024
- MVIS 11-07-2024
- Dividend Yield
- OCGN N/A
- MVIS N/A
- EPS Growth
- OCGN N/A
- MVIS N/A
- EPS
- OCGN N/A
- MVIS N/A
- Revenue
- OCGN $4,700,000.00
- MVIS $8,147,000.00
- Revenue This Year
- OCGN N/A
- MVIS $24.78
- Revenue Next Year
- OCGN N/A
- MVIS $322.28
- P/E Ratio
- OCGN N/A
- MVIS N/A
- Revenue Growth
- OCGN N/A
- MVIS 277.53
- 52 Week Low
- OCGN $0.36
- MVIS $0.83
- 52 Week High
- OCGN $2.11
- MVIS $2.98
- Technical
- Relative Strength Index (RSI)
- OCGN 44.59
- MVIS 50.35
- Support Level
- OCGN $0.85
- MVIS $1.03
- Resistance Level
- OCGN $0.94
- MVIS $1.06
- Average True Range (ATR)
- OCGN 0.08
- MVIS 0.06
- MACD
- OCGN -0.01
- MVIS 0.00
- Stochastic Oscillator
- OCGN 19.64
- MVIS 65.22
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.